Who
Aimee J. Lenar
President, US Pharma
Company insider
Files Form 4 as: President, US Pharma, Bausch Health Companies.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $518K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jul 2024
- Last trade
- 19 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 20 Aug 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $259K36,827 at $7.03 | filing |
| 19 Aug 2026filed 20 Aug 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $259K36,827 at $7.03 | filing |
| 17 Jul 2026filed 20 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $25K5,260 at $4.83 | filing |
| 17 Jul 2026filed 20 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $25K5,260 at $4.83 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $114K23,395 at $4.89 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $114K23,395 at $4.89 | filing |
| 26 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $106K17,578 at $6.04 | filing |
| 26 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $106K17,578 at $6.04 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —157,139 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —157,139 at $0.00 | filing |
| 17 Jul 2025filed 18 Jul 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —30,847 at $0.00 | filing |
| 15 Jul 2025filed 16 Jul 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $146K22,736 at $6.42 | filing |
| 26 Feb 2025filed 28 Feb 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —108,311 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —144,352 at $0.00 | filing |
News
Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)BHC · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Aimee J. Lenar; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.